No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Dimerix Appoints Nonexecutive Chair
Antisense Therapeutics Launches Share Sale Facility for Unmarketable Parcels
Antisense Therapeutics' Share Purchase Plan Raises AU$3.3 Million
Antisense Therapeutics Price Target Cut 12% to A$0.23/Share by Morgans
Antisense Therapeutics Appoints CEO/Managing Director
ASX Closes 0.85% Higher: Rio Tintos Half-year Profit Gets Slammed
No Data